Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(1.71)
# 3,412
Out of 5,131 analysts
205
Total ratings
22.86%
Success rate
-7.13%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRDL Cardiol Therapeutics | Reiterates: Buy | $9 | $1.00 | +802.44% | 10 | Apr 16, 2025 | |
| GOVX GeoVax Labs | Reiterates: Buy | $8 | $0.17 | +4,730.92% | 15 | Apr 16, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.71 | +232.75% | 8 | Apr 11, 2025 | |
| PHIO Phio Pharmaceuticals | Reiterates: Buy | $4 | $1.16 | +244.83% | 7 | Apr 8, 2025 | |
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $2.10 | -4.76% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $200 | $3.98 | +4,925.13% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.22 | +755.86% | 7 | Mar 20, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $1.50 | +1,300.00% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.17 | +1,182.05% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $560 | $2.38 | +23,429.41% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $120 | $3.96 | +2,930.30% | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $7.22 | +454.02% | 9 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.42 | +2,012.68% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.27 | +161.35% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.73 | +824.86% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.95 | +531.58% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $0.89 | +11,165.07% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $54,000 | $4.14 | +1,304,247.83% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.63 | +660.46% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.65 | +338,609.68% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $15.65 | +3,094.89% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $35.58 | +574.63% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $1.05 | +7,519.05% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $13.30 | +60,050.38% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.34 | +422.39% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $1.72 | +1,644.19% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $5.56 | +619.42% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $5.48 | +228.47% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.15 | +58.73% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $62.51 | -61.61% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $0.83 | +410,464.23% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $1.27 | +1,495,962.99% | 1 | Oct 6, 2017 |
Cardiol Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $9
Current: $1.00
Upside: +802.44%
GeoVax Labs
Apr 16, 2025
Reiterates: Buy
Price Target: $8
Current: $0.17
Upside: +4,730.92%
Candel Therapeutics
Apr 11, 2025
Reiterates: Buy
Price Target: $19
Current: $5.71
Upside: +232.75%
Phio Pharmaceuticals
Apr 8, 2025
Reiterates: Buy
Price Target: $4
Current: $1.16
Upside: +244.83%
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $2.10
Upside: -4.76%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $200
Current: $3.98
Upside: +4,925.13%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.22
Upside: +755.86%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $1.50
Upside: +1,300.00%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.17
Upside: +1,182.05%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $560
Current: $2.38
Upside: +23,429.41%
Mar 6, 2025
Reiterates: Buy
Price Target: $120
Current: $3.96
Upside: +2,930.30%
Mar 5, 2025
Reiterates: Buy
Price Target: $40
Current: $7.22
Upside: +454.02%
Mar 4, 2025
Reiterates: Buy
Price Target: $30
Current: $1.42
Upside: +2,012.68%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.27
Upside: +161.35%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $1.73
Upside: +824.86%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $0.95
Upside: +531.58%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $0.89
Upside: +11,165.07%
Nov 12, 2024
Reiterates: Buy
Price Target: $54,000
Current: $4.14
Upside: +1,304,247.83%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $2.63
Upside: +660.46%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.65
Upside: +338,609.68%
Mar 8, 2023
Reiterates: Buy
Price Target: $500
Current: $15.65
Upside: +3,094.89%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $35.58
Upside: +574.63%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $1.05
Upside: +7,519.05%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $13.30
Upside: +60,050.38%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.34
Upside: +422.39%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $1.72
Upside: +1,644.19%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $5.56
Upside: +619.42%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $5.48
Upside: +228.47%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $3.15
Upside: +58.73%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $62.51
Upside: -61.61%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $0.83
Upside: +410,464.23%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $1.27
Upside: +1,495,962.99%